Answers are grounded in this paper and cite their sources.
Primary biliary cirrhosis, a slowly progressive autoimmune liver disease characterized by portal inflammation and an immune-mediated destruction of the intrahepatic bile ducts, leads to decreased bile secretion and the retention of toxic substances within the liver. This review considers new data concerning both the autoimmune responses involved and the treatment of primary biliary cirrhosis.
No takes yet. Share an insight, caveat, or question.
Kaplan et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: